Trust
References & Evidence Library
Primary sources cited across SleevePlus.mx educational pages.
Sleeve Plus & magnetic anastomosis
- Gagner M, et al. Laparoscopic Sleeve Gastrectomy with Duodeno-Ileal Magnetic Anastomosis: early clinical outcomes. Peer-reviewed publications reporting 12–24 month follow-up.
- U.S. FDA 510(k) clearance documentation for the MagDI System (magnetic duodeno-ileostomy device).
Bariatric & metabolic surgery — professional societies
- American Society for Metabolic and Bariatric Surgery (ASMBS) — clinical guidance and position statements
- International Federation for the Surgery of Obesity (IFSO) — global consensus documents
- American Diabetes Association (ADA) — Standards of Care in Diabetes
- American Association of Clinical Endocrinology (AACE) — obesity and diabetes guidelines
- European Association for the Study of Diabetes (EASD) — consensus reports
Government health agencies
- National Institutes of Health (NIH) — patient education on bariatric surgery
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — obesity and weight-management resources
- Centers for Disease Control and Prevention (CDC) — obesity epidemiology
GLP-1 pharmacotherapy
- STEP program publications — semaglutide clinical trial results
- SURMOUNT program publications — tirzepatide clinical trial results
- FDA prescribing information for approved GLP-1 receptor agonists
Studies of newer procedures often report 12–18 month follow-up; longer-term durability continues to accumulate. Ranges and figures cited in our educational content reflect published averages and are not predictions of individual results. See treatment results disclaimer.
Last reviewed: June 2026.